Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

Kolkata: Prices of 42 medicines, including those used for day-to-day consumption, are likely to change following an order by ...

New research from the University of Birmingham and Aston University has found that putting lower-calorie meal choices at the ...

SGLT-2 inhibitors canagliflozin, empagliflozin, and dapagliflozin showed overall comparable effectiveness on cardiovascular outcomes in T2D.

Experts are now calling for NHS guidance - which does not recommend managing diabetes with different drugs depending on age - ...